Office of Research & Development |
|
Project Number: | I01BX004270-04A1 |
Title: | Development of Novel Second Generation Anti-inflammatory Substrate-selective p38 MAP Kinase Inhibitors as Therapy for Acute Respiratory Distress Syndrome |
Principal Investigator: | Jeffrey D. Hasday |
Location: | Baltimore, MD |
Congressional District Code: | 7 |
Research Service: | Biomedical Laboratory R&D |
Project Period: | January 2022 - December 2025 |
FY 2024 Funding Amount: | $164,992 |
Abstract: |
View abstract and other project information on NIH RePORTER Go To NIH RePORTER |